Developing targeted therapies for biologically defined sub-populations.
Biossil is an applied AI drug discovery platform developing targeted therapies for biologically defined patient sub-populations. Biossil is focused on diseases for which traditional drug discovery has been challenged by population variability.
Golden Venture Partners is Investor in Toronto
Your signup was successful. To complete the process of registering your first name, please refer to your email and confirm the email received from us.
We found a number of people with your first name. When you find your first name in this list, select it